2017 Global Ambulatory Surgery Center

Market Overview

QYRESEARCH PUBLISHING

http://www.qyresearch.com

Email: sales@qyresearch.com; Tel: 020-86655165; http://www.qyresearch.com 1

Author: Zhang Chunjiao

Company: QYResearch Center

Date: 2017/4/28

Recently, QYResearch published a report on ambulatory surgical centers (ASCs) market. The
global ambulatory surgical centers (ASCs) market is currently witnessing relatively fast
growth mainly due to an increasing demand for quick, cost-effective, and high-quality
medical services as a viable alternative to inpatient care. In terms of revenue the global
ambulatory surgical centers market is projected to expand at a CAGR of 3.95% during the
forecast period (20122022) and is expected to be valued at 94.5 B USD by the end of 2022
projecting a 1.47X increase during this period. Market growth is likely to be driven largely by
the rise in healthcare spending along with a growing number of ASCs.

The global ambulatory surgical centers market is highly fragmented with top five leading
companies, which include AmSurg, THC, HCA Healthcare, Mednax and Team Health
accounting for approximately 14% of the overall market in 2017. In this report, the major
players include AmSurg, THC, HCA Healthcare, Mednax, Team Health, Surgical Care
Affiliates, QHC, Surgery Partners, Medical Facilities, Terveystalo Healthcare, SurgCenter
Development, Healthway Medical, Eifelhoehen-Klinik and etc.

The global ambulatory surgical centers market is segmented based on center type into single
specialty centers and multi-specialty centers; based on modality into hospital-based
ambulatory surgical centers and freestanding ambulatory surgical centers; based on services
into diagnostic services and surgical services; and based on specialty area into
gastroenterology, ophthalmology, orthopedics, pain/neurology, urology, dermatology, and
others. The hospital-based ambulatory surgical centers segment is expected to witness
relatively higher growth rates in terms of value in the global ambulatory surgical centers
market over the forecast period. Currently, the gastroenterology (revenue market share 31.6%
in 2017) specialty area segment accounts for a relatively higher revenue share, followed by

Email: sales@qyresearch.com; Tel: 020-86655165; http://www.qyresearch.com 2

ophthalmology (revenue market share 28.3% in 2017) and pain/neurology segments (revenue
market share 21.6% in 2017).

This article was first released by QYResearch analyst, if reproduced, please indicate
the source.
Media Contact:press@qyresearch.com
Analyst :zhangchunjiao@qyresearch.com

Email: sales@qyresearch.com; Tel: 020-86655165; http://www.qyresearch.com 3